Save 20% off your first order using our new site with code HELLO! Expires November 30th.

AAPPTec Custom Peptides in the Literature

AAPPTec provides high quality custom peptides to researchers around the world. Below are a few examples of recent papers where AAPPTec custom peptides were utilized. Click on the title to go to the paper or abstract.

Elucidation of Aggregation Pathways of Helix-Turn-Helix Peptides: Stabilization at the Turn Region Is Critical for Fibril Formation”, Do, TD; Chamas, A; Zheng, X; Barnes, A; Chang, D; Veldstra, T; Takhar, H; Dressler, N; Trapp, B; Miller, K; McMahon, A; Meredith, SC; Shea, J-E; Cantrell, KL; Bowers, MT., Biochemistry, 2015, 54, 4050-62.

Defining Species-Specific Immunodominant B Cell Epitopes for Molecular Serology of Chlamydia Species”, Rahman, KS; Chowdhury, EU; Poudel, A; Ruettger, A; Sachse, K; Kaltenboeck, B., Clin. Vaccine Immunol., 2015, 22, 539-52.

“Keratin 1 Plays a Critical Role in Golgi Localization of Core 2 N-Acetylglucosaminyltransferase M via Interaction with Its Cytoplasmic Tail”, Petrosyan, A; Ali, MF; Cheng, P-W., J. Biol. Chem., 2015, 290, 6256-6269.

CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppresion and Targeting Cancer-Initiating Cells“, Gil, M; Komorowski, MP; Seshadri, M; Rokita, H; McGray, AJR; Opyrchal, M; Odunsi, KO; Kozbor, D., J. Immunol., 2014, 193, 5327-5337.

Gamma-Secretase Processing and Effects of gamma-Secretase Inhibitors and Modulators on Long Aβ Peptides in Cells”, Ran, Y; Cruz, PE; Ladd, TB; Fauq, AH; Jung, JI; Matthews, J; Felsenstein, KM; Golde, TE., J. Biol. Chem., 2014, 289, 3276-3287. DOI: 10.1074/jbc.M113.512921

Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3”, Kamadurai, HB; Qiu, Y; Deng, A; Harrison, JS; MacDonald, C; Actis, M; Rodrigues, P; Miller, DJ; Souphron, J; Lewis, SM; Kurinov, I; Fujii, N; Hammel, M; Piper, R; Kuhlman, B; Schulman, BA., eLife Sci, Aug 2013; 2, e00828. DOI: 10.7554/eLife.00828

Role of Aldose Reductase in the Metabolism and Detoxification of Carnosine-Acrolein Conjugates”, Baba, SP; Hoetker, JD; Merchant, M; Klein, JB; Cai, J; Barski, OA; Conklin, DJ; Bhatnagar, A., J. Biol. Chem., 2013; 288, 28163 – 28179. DOI: 10.1074/jbc.M113.504753

Chemokine CXCL1 Dimer Is a Potent Agonist for the CXCR2 Receptor”, Ravindran, A; Sawant, KV; Sarmiento, J; Navarro, J; Rajarathnam, K., J. Biol. Chem., 2013, 288, 12244 – 12252. DOI:10.1074/jbc.M112.443762

Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases”, Gil, M; Seshadri, M; Komorowski, MP; Abrams, SI; Kozbor, D., Proc. Natl. Acad. Sci., 2013, 110, E1291-E1300. DOI: 10.1073/pnas.1220580110


Spiral counter-current chromatography of small molecules, peptides and proteins using the spiral tubing support rotor”, Knight, M; Finn, TM; Zehmer, J; Clayton, A; Pilon, A., J.Chromatogr. A, 2011, 1218, 6148–6155.

1. Ribeiro de Noronha, SM; Correa-Noronha, SAA; Russo, IH; Lopez, R; Pereira, JS; Russo, J. “Abstract 2299: IL-8 receptor CXCR1 expressed in human breast epithelial cells MCF-10F is down regulated by human chorionic gonadotropin and its peptide 81-95” Cancer Res., 2011, 71, 2299.
2. Phelps EA, Landázuri N, Thulé PM, Taylor R, García AJ. “Bioartificial Matrixes for Therapeutic Vascularization” PNAS, 2010, 107, 3323-8.
3. Lefkowitz, RB; Schmid-Schönbein, GW; Heller, MJ. “Whole Blood Assay for Elastase, Chymotrypsin, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Activity” Anal. Chem., 2010, 82, 8251-8. DOI: 10.1021/ac101462c
4. Cai, J; Bhatnagar, A; Pierce, WM., Jr. “Protein Modification by Acrolein: Formation and Stability of Cysteine Adducts” Chem. Res. Toxicol., 2009, 22, 708-16. DOI: 10.1021/tx800465m

Abstract 2299: IL-8 receptor CXCR1 expressed in human breast epithelial cells MCF-10F is down regulated by human chorionic gonadotropin and its peptide 81-95”, Ribeiro de Noronha, SM; Correa-Noronha, SAA; Russo, IH; Lopez, R; Pereira, JS; Russo, J., Cancer Res., 2011, 71, 2299. DOI: 10.1158/1538-7445.AM2011-2299 DOI: 10.1016/j.chroma.2011.06.007

Bioartificial Matrixes for Therapeutic Vascularization”, Phelps EA, Landázuri N, Thulé PM, Taylor R, García AJ., Proc. Nat. Acad. Sci. USA, 2010, 107, 3323-8. DOI: 10.1073/pnas.0905447107

Whole Blood Assay for Elastase, Chymotrypsin, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Activity”, Lefkowitz, RB; Schmid-Schönbein, GW; Heller, MJ., Anal. Chem., 2010, 82, 8251-8. DOI: 10.1021/ac101462c

Protein Modification by Acrolein: Formation and Stability of Cysteine Adducts”, Cai, J; Bhatnagar, A; Pierce, WM., Jr., Chem. Res. Toxicol., 2009, 22, 708-16. DOI: 10.1021/tx800465m